Skip to main content
  1. Home
  2. Emerging Tech
  3. Cars
  4. News

Painted optical illusion road blocks trick drivers into slowing down near school zones in India

Add as a preferred source on Google

Speed bumps and zebra crossings aim to slow down road traffic, but that doesn’t mean every driver obeys those kinds of road warnings. That’s why the city of Ahmedabad, India took painted road instructions a step further, and created optical illusions that look like three-dimensional road blocks when approached from the right angle.

A highway management company in Ahmedabad commissioned local artists Saumya Pandya Thakkar and Shakuntala Pandya to paint the optical illusion crosswalks in school zones. “A lot of school kids were crossing the road, and it was not safe for them because of the high speed of the highway,” said Thakkar. Drawing inspiration from similar crosswalk illusions that had been painted in China, the duo painted a total of four highway crosswalks in Ahmedabad’s school zones.

Painted road block optical illusions stop traffic accidents in Ahmedabad
FastCo
FastCo
Recommended Videos

Since completing the project in January, Ahmedabad highway officials have reported that accidents have been eliminated in those four dangerous traffic areas. The illusion is effective because at a distance, drivers’ eyes are tricked into believing there is a three-dimensional roadblock in the middle of the highway. After slowing down on approach, drivers can clearly see that the blockage is an optical illusion as they near the painting, so they don’t brake completely or stop the flow of traffic.

If anything else, getting drivers to pay attention to their speeds in active school zones has had a positive impact. “It’s not that dangerous for the drivers, because they can make out that this is just a painting. But the idea is that they pay attention because of the new creations,” said Thakkar. And for any driver with a sense of humor, the optical illusions might even send them on their day with smiles on their faces.

Chloe Olewitz
Former Digital Trends Contributor
Chloe is a writer from New York with a passion for technology, travel, and playing devil's advocate. You can find out more…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more